As of 28 October 2025, the Health Technology Assessment Council has completed the evidence appraisal on the assessment of moderate complexity nucleic acid amplification tests (NAATs) for the diagnosis multi-drug resistant tuberculosis (MDR-TB) with simultaneous isoniazid (INH) and rifampicin (Rif) resistance testing for possible government financing. The HTA Council hereby releases its preliminary recommendation on continue reading : HTA Council Preliminary Recommendation on Moderate Complexity Nucleic Acid Amplification Tests (NAAT) for the Diagnosis of Multi-drug Resistant Tuberculosis (MDR-TB) with Simultaneous Isoniazid and Rifampicin Resistance Testing